Energenesis Biomedical CO.,LTD. operates in the biomedicine industry in Taiwan. It provides ENERGI-F703, which is Phase III clinical trial for use in treatment of diabetic foot ulcers; ENERGI-F701, a topical tonic for the treatment of alopecia that is in Phase II clinical trial; ENERGI-F711, a burn cream; ENERGI-F703VLU, a gel that treats venous leg ulcers; ENERGI-F703EB, a topical cream for treating wounds in hereditary epidermolysis bullosa; ENERGI-F702 to treat metabolic diseases; ENERGI-F704 for the treatment of inflammatory bowel disease; ENERGI-F708 for asthma treatment; ENERGI-F705 for Parkinson's disease control; ENERGI-F707 for the treatment of mitochondria deficiency; ENERGI-F706 to treat cachexia; ENERGI-F709, a vaccine adjuvant; and ENERGI-F710 for blood phosphate control. The company also offers scientific products, including western blot, cell culture supplement, protein isolation, protein quantification, dyes, and buffer solutions. Energenesis Biomedical CO.,LTD. was founded in 2012 and is based in Taipei, Taiwan.
Frequently asked questions
What sector does Energenesis Biomedical Co. Ltd. (6657) operate in?
Energenesis Biomedical Co. Ltd. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Energenesis Biomedical Co. Ltd. (6657) current stock price?
As of the latest data, Energenesis Biomedical Co. Ltd. stock price is NT$30.95, with a previous close of NT$31.55. Energenesis Biomedical Co. Ltd. lost -NT$0.60 in the last trading session, representing a -1.9% loss.
What is Energenesis Biomedical Co. Ltd. (6657) current market capitalization?
Energenesis Biomedical Co. Ltd. market cap is approximately 2.72 billion.
What is Energenesis Biomedical Co. Ltd. (6657) Earnings Per Share (EPS)?
The trailing EPS is -NT$2.92.
What is Energenesis Biomedical Co. Ltd. (6657) EBITDA?
Energenesis Biomedical Co. Ltd. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -47.24 million.
Does Energenesis Biomedical Co. Ltd. (6657) pay dividends?
No. Energenesis Biomedical Co. Ltd. does not pay a dividend.
What is Energenesis Biomedical Co. Ltd. (6657) beta (volatility) score?
Energenesis Biomedical Co. Ltd. has a beta of 0.426, indicating lower volatility than the overall market.
